|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 14/55 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 2970486 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14723938.8 |
| Date of filing the European patent application | 2014-03-17 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/030758 |
| Date | 2014-03-17 |
| (87) | Number | WO 2014/145907 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 201361800743 P | 2013-03-15 | US | |
| 201361911438 P | 2013-12-03 | US |
| (72) |
CHU, Seung, US
WICKRAMARACHICHI, Dilki, US
BERNETT, Matthew, J., US
DESJARLAIS, John, US
|
| (73) |
Xencor, Inc.,
111 W. Lemon Avenue, Monrovia, CA 91016,
US
|
| (54) | MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS |
| MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS |